News Digest / Ticker: APGE

Ticker: APGE

02:47am, Thursday, May 28, 2026

Apogee Therapeutics Soars After $1.3B Deal with Blackstone Life Sciences

Apogee Therapeutics shares surge nearly 16% pre-market following a $1.3 billion financing deal with Blackstone Life Sciences to support its atopic dermatitis drug, zumilokibart.

08:06am, Monday, Aug 11, 2025

Apogee's APG777 shows strong Phase 2 results; well-funded but burning cash fast

Snapshot - Apogee Therapeutics, Inc. (APGE) (NASDAQ: APGE) What's happening inside: the company is accelerating clinical development (positive 16‑week Part A APEX data for APG777 announced), funding multiple programs (APG777, APG279, APG990, APG333, APG808) while spending heavily - cash + securit...